 | Annovis Bio, Inc. | |||
| NYQ : ANVS || Location: United States | ||||
$10.06+0.21 (+2.13%) |
0.22 M | 9.62 - 10.18 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.505 M |
| March 15, 2024 | 1.348 M |
| Feb. 29, 2024 | 1.475 M |
| Feb. 15, 2024 | 1.368 M |
| Jan. 31, 2024 | 1.311 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.33 | -2.24 | -68.35% |
| 09/30/2023 | -1.11 | -1.63 | -46.57% |
| 06/30/2023 | -1.16 | -1.07 | 8.12% |
| 03/31/2023 | -0.34 | -1.19 | -249.28% |
| 12/31/2022 | -1.07 | -0.38 | 64.61% |
ANVS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 11.011M | Shares Float | 8.143M |
| Short Float | 1.505M | Market Cap | 110.77M |
| Institution ownership | 11.49% | Insider ownership | 24.593% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -6.23 | Forward EPS | -2.52 |